Finance

Lists
Why is APRE down 4.07%?
Dive Deeper
APRE:NASDAQ
Aprea Therapeutics Inc
$0.56
-4.07%
(-0.024) 1D
Oct 19, 11:05:15 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for APRE...
Open
$0.60
High
$0.61
Low
$0.56
Mkt. cap
7.11M
Avg. vol.
219.91K
Volume
36.16K
52-wk high
$1.69
52-wk low
$0.55
EPS
-$1.08
Beta
1.66
Shares outstanding
12.59M
No. of employees
8
Open
$0.60
High
$0.61
Low
$0.56
Mkt. cap
7.11M
Avg. vol.
219.91K
Volume
36.16K
52-wk high
$1.69
52-wk low
$0.55
EPS
-$1.08
Beta
1.66
Shares outstanding
12.59M
No. of employees
8
News stories
From web sources and news partners
About Aprea Therapeutics Inc
CEO-
Employees8
Founded-
Headquarters-
SectorBiotechnology
Websiteaprea.com
Analyst ratings
Based on 4 analysts giving stock ratings to APRE in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for APRE in the last 3 months.
Highest
Current $0.56
$5.00 (+792.22%)
Average
$3.30 (+488.87%)
Lowest
$1.20 (+114.13%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Initiated
$2.00
+256.9%
10/14/2026
Jason McCarthy
Maxim Group
Buy
Reiterated
$5.00
+792.2%
08/14/2026
Jay Olson
Oppenheimer
Buy
Reiterated
$5.00
+792.2%
08/13/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
$1.20
+114.1%
08/13/2026
Robert Driscoll
Wedbush
Buy
Reiterated
$6.00
+970.7%
05/14/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.85K
3.34K
-
-
Cost of goods sold
1.64M
1.01M
1.61M
2.46M
Cost of revenue
1.64M
1.01M
1.61M
2.46M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.48M
1.64M
1.82M
1.57M
Operating expense
1.48M
1.64M
1.82M
1.57M
Total operating expenses
3.12M
2.65M
3.43M
4.03M
Operating income
-3.12M
-2.64M
-3.43M
-4.03M
Other non operating income
-
77.50K
-
79.00K
EBT including unusual items
-2.97M
-2.46M
-3.29M
-3.59M
EBT excluding unusual items
-2.97M
-2.46M
-3.29M
-3.59M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.97M
-2.46M
-3.29M
-3.59M
Net profit margin
-160,844.70%
-73,587.95%
-
-
Earnings per share
-0.47
-0.32
-0.22
-0.07
Interest and investment income
150.67K
118.66K
134.78K
358.92K
Interest expense
-
-
-
-
Net interest expenses
150.67K
118.66K
134.78K
358.92K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.11M
-2.64M
-3.42M
-4.03M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps